Take Back Health

The media sure does have a way of making parents second-guess well-informed decisions. Since Covid, I have seen the media blow up news stories about monkeypox, bird flu, and most recently, measles. No one wants to see their child sick. Good parents don’t want their children to suffer. There is nothing wrong with re-evaluating previous decisions when faced with new information, but decisions should be made with exactly that—information. The best way to face fear is with facts. So let’s take a look at the measles virus and vaccine and evaluate the risks and benefits.

Risks of Measles Virus

The mortality rate of measles dropped in the 1950s as nutrition and hygiene improved. By 1963, measles mortality (deaths) had declined by 98.5%. The measles vaccine was manufactured in 1963. (Vaccines, Autoimmunity, and the Changing Nature of Childhood Illness by Thomas Cowan, MD. pg 100-101)

Globally, approximately one in 1,000 measles cases is fatal — a statistic I found from multiple resources doing a simple Google search. It is important to note this is a global statistic, including impoverished and malnourished areas. However, in industrialized countries, the fatality rate of measles is 1 in 10,000. For those who are not deficient in Vitamin A, the risk of hospitalization and fatality is 1 in 93,0000.

Most cases are mild. The virus causes a fever, red rash, red eyes, runny nose, and cough. Symptoms are similar to other illnesses, so laboratory testing is used to diagnose. A mild case lasts about a week. Moderate cases are less common but may involve ear infection, pneumonia, or other complications and a higher fever. Severe cases of measles can cause encephalitis or other serious complications that require medical care. (The Vaccine Book pg. 81-82)

Statistics of severe complications:
Encephalitis occurs in 1 in 20,000 cases with permanent disability occurring in 1 in 80,000 cases.
About 3 in 1,000 cases see seizure
About 7 in 1,000 cases require hospitalization.
About 6-22 in 1,000,000 develop SSPE.

We should also note that the CDC defines a measles outbreak as three or more related cases.

Risks of Measles Vaccine

ADVERSE EVENTS

“As of January 31, 2025, there have been 115,849 reports of measles-vaccine reactions, hospitalizations, injuries, and deaths following measles vaccinations made to the federal Vaccine Adverse Events Reporting System (VAERS), including 572 related deaths, 8,971 hospitalizations, and 2,207 related disabilities.  Approximately 50 percent of those adverse events occurred in children under three years old.” 

VAERS is a reporting system used by doctors and patients to report vaccine reactions.) It is estimated that less than one percent of vaccine reactions are reported.

“As of January 1, 2025, there have been 1,379 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following measles vaccination, 85 deaths and 1,294 serious injuries.” Read more at the National Vaccine Information Center.

VICP claims can only be filed if the Department of Human Health and Services determines a petition meets the required medical criteria and if the Department of Justice submits it to the Vaccine Court.

INGREDIENTS
The ingredients of a vaccine can be found in section 11 of the vaccine package insert. The package inserts are available on the FDA website. A fetal cell lines chart is available from COGFL.org. Below are the ingredients that concerned me:

MMRII made by Merck
Chick embryo cell culture
RA 273 (aborted fetal cells, gender unknown, 6 weeks gestation, took 99 abortions to find this cell line that worked)
WI-38 (aborted fetal cells, female, 12 weeks gestation, 32nd abortion to create this cell line)
Hydrolyzed gelatin
Fetal bovine serum
Neomycin (antibiotic)
“Other buffer and media ingredients” (What are these? Why are they left unnamed?)

PRIORIX by Glaxosmithkline
Chick embryo fibroblasts
RA 273 (aborted fetal cells, gender unknown, 6 weeks gestation, took 99 abortions to find this cell line that worked)
MRC-5 (aborted fetal cells, male, 14 weeks gestation, aborted for psychiatric reasons for 27-year-old healthy woman, fifth abortion to create this cell line)
Neomycin
Bovine Serum

ProQuad by Merck (MMR and chickenpox)
Chick embryo cell culture
RA 273
MRC-5
Bovine serum
Hydrolyzed gelatin
monosodium L-glutamate (MSG)

The package inserts caution in giving the vaccine to anyone with reactions to eggs or gelatin. An excellent compilation of research concerning the injection of food proteins causing food allergies is the book The Peanut Allergy Epidemic by Heather Fraser.

HUMAN DNA

The Corvelva Study of the Priorix vaccine determined that there are no human DNA fragments, but an entire, intact human genome in the vaccine. All the chromosomes of the male baby are present in the cell line. In addition, the cell line is likely tumorigenic (produces tumors).

Foreign human DNA causes another problem: autoimmune disease. Dr. Theresa Deisher wrote a letter to legislators explaining that injecting animal DNA causes an immune response because the body detects it as foreign and attacks it. Foreign human DNA is similar to the recipient’s DNA, causing the body to sometimes attack both the foreign and its own DNA, resulting in autoimmune disease.

Dr. Deisher says in her letter, “Levels [of foreign human DNA] in our children can reach up to 5 ng/ml after vaccination, depending on the age, weight, and blood volume of the child. That level is known to activate Toll-like receptor 9 (TLR9), which can cause autoimmune attacks.” To better explain, Dr. Deisher uses the example of a pregnant mother going into labor.  When enough of the baby’s DNA builds up in the mother’s bloodstream, she goes into labor. “When [levels] reach between 0.46– 5.08 ng/mL, they trigger labor via the TLR9 mechanism…. The fetal DNA levels in a child after being injected with fetal-manufactured vaccines reach the same level that triggers autoimmune rejection of baby by mother… If fetal DNA can trigger labor (a naturally desired autoimmune reaction), then those same levels in vaccines can trigger autoimmunity in a child.”

Auto-immune diseases are listed as adverse events in MMR package inserts.

CONTAMINANTS

In addition to a full genome, Corvelva discovered contaminating viruses. The contaminating viruses are: Human endogenous retrovirus K, Equine infectious anemia virus, Avian leukosis virus, HERV-H / env62. These viruses are potentially dangerous, according to Corvelva. Other microbial contaminants included Proteobacteria and nematode-helminth.

AUTISM

Do all people who receive vaccines develop autism? Of course not. However, there are documented cases in which children had extreme regression after vaccination, putting them on the spectrum. To deny this is to gaslight parents who have witnessed severe injury to their children. To ignore this is neither right nor safe, but a selfish action of pharmaceutical companies and government agencies who financially benefit from vaccines, yet they are protected from liability. In addition, out of 23 autism/vaccine studies performed by 2011, eighteen of them were funded by vaccine manufacturers who would be held liable if a link was found. (Sears, pg 188) Meanwhile, there are studies showing causation is a possibility. See studies published in Issues in Law and Medicine, Academic Journals, and Journal of Biomedical Science. More research must be done before one can truthfully say, “Vaccines do not cause autism.”

SHEDDING

Section 5.6 of the ProQuad package insert states that those recently vaccinated with ProQuad can transmit viruses to others. People most at risk of exposure to a person recently vaccinated with a live-vaccine are the elderly, newborn babies, pregnant women, and the immunocompromised. The ProQuad package insert states, “Vaccine recipients should attempt to avoid, to the extent possible, individuals susceptible to varicella for up to six weeks following vaccination.” Both the ProQuad and Priorix package inserts state in section 5.6, “Live attenuated rubella vaccine virus has been detected in the nose and throat of individuals 7 to28 days after vaccination with a rubella virus-containing vaccine.”

There was a case study where a measles strain was found in nose and throat cultures of a recently vaccinated child. Another case report showed that measles vaccination can result in respiratory excretion of the virus.

LOSS OF IMMUNITY

A 2014 case report in Clinical Infectious Diseases showed that measles can be spread from one fully-vaccinated person to another fully-vaccinated person. A case report in the Journal of Infectious Diseases demonstrated the spread of measles in vaccinated populations, with a vulnerability in people who received 2 doses. A Danish study showed a loss of immunity for measles, mumps, and rubella in vaccinated individuals. This is why even vaccinated pregnant women are routinely checked for rubella antibodies in labwork done in the first trimester. Many medical students must have their titers checked, and many must have the MMR series again when titers show no immunity despite being vaccinated as a child. A 2021 Italian study published in Human Vaccines and Immunotherapies showed that recipients of a two-dose vaccine showed a decline in immunity. The study states, “It is highly unlikely that measles will be eliminated in the immediate future, a part of individuals vaccinated several years ago will soon lose their circulating antibodies, such that outbreaks of the disease in the coming years can be expected.” The study also states, “Natural immunity is both more robust and longer-lasting than vaccine immunity.” A 2007 study in Archives of Pediatric and Adolescent Medicine had similar results.

Loss of immunity is a problem because measles is often more severe in adulthood. This means vaccine immunity wears off when the disease is more likely to cause a severe case. However, the disease is most often mild in children older than 5, and it creates lifelong immunity.

Measles Vaccine Benefits

The obvious benefit of the vaccine is creating temporary immunity to measles, mumps, and rubella.

Measles Virus Benefits

The measles virus could have potential benefits. Immune responses, like fevers, have been linked to benefits. Fevers may make us more resilient to cancer. This is why some cancer treatments use hyperthermia therapy, in which the affected body tissue is heated to as high as 113°F. Studies suggest that childhood diseases, like measles, may decrease the risk of later developing Hodgkin’s and non-Hodgkin’s lymphomas, including a study published in Leukemia Research, the International Journal of Cancer, and the British Journal of Cancer. A study published in Melanoma Research suggests that those who had febrile infections as children were less likely to develop skin cancer. In addition, there have been cases of spontaneous tumor regression during natural measles infection, and the use of the measles virus as a cancer treatment has been explored, as published in Current Topics in Microbiology and Immunology, Clinical Pharmacology and Therapeutics, and Gene Therapy.

Measles infection in childhood may protect against more than just cancer. A study published in Atherosclerosis shows that measles infection may protect against heart attacks and strokes in adulthood. Studies published in the Lancet and Pediatrics have demonstrated measles disease may protect against allergic disease in children.

Infants born to women with natural measles immunity had better protection from measles than infants born to vaccinated women. Studies in Epidemiology and Infection and the Journal of Infectious Diseases show that infants born to vaccinated mothers had lower levels of measles antibodies, and these became undectable more quickly than infants of mothers with natural immunity. Measles vaccination leaves infants more prone to infection during a vulnerable time.

Measles Treatment

Vitamin A can reduce morbidity and mortality by over 80%, according to The American Journal of Clinical Nutrition, Journal of Tropical Pediatrics (2002), and the British Medical Journal.

The WHO and AAP recommend the following doses of Vitamin A
Age one and up: 200,000 IU
Ages 6-12 months: 100,000 IU
Younger than 6 months: 50,000 IU

More studies evidencing Vitamin A as an effective treatment for measles:
Journal of Tropical Pediatrics (1993)
American Journal of Diseases of Children (1992)
New England Journal of Medicine (1990)

An excellent book to keep on hand is The Unvaccinated Child: A Treatment Guide for Parents and Caregivers by Judith Thompson, ND and Eli Camp, ND, DHANP.

Summary

• The risks of severe complications and fatalities caused by the measles virus have decreased greatly with hygiene and nutritional advances before the vaccine came out.
• The risk of fatality in industrialized countries is 1 in 10,000 and even better for those not deficient in Vitamin A.
• There have been thousands of reports of vaccine injury in VAERS and claims in VICP.
• Vaccine ingredients have the potential to cause severe side effects.
• Foreign human DNA from aborted babies in vaccines has the ability to cause autoimmune disease.
• Immunity lasts longer from natural infection than from vaccines.
• Immunity transferred from mother to child is more robust and lasts longer in infants born to mothers with natural immunity.
• Childhood measles infection has a correlation with a decreased risk of some cancers, allergy diseases, heart attacks, and stroke later in life.
• Vitamin A is an effective treatment for measles.

This article does not contain any affiliate links.
Return to Home Page.